ACCELERON PHARMA INC. Operating Cash Flow
ACCELERON PHARMA INC. reported Operating Cash Flow of -$223.23 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-11-04
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$70.89M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$84.42M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$67.92M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$38.13M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for fiscal 2020 was -$130.33M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for fiscal 2019 was -$93.80M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for fiscal 2018 was -$94.71M.
- ACCELERON PHARMA INC. net cash provided by (used in) operating activities for fiscal 2017 was -$76.54M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$70.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$155.30M derived: sum of 2 quarters · filed 2021-11-04 | -$223.23M 10-Q · filed 2021-11-04 | -$261.36M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2021-06-30 | -$84.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$152.34M 10-Q · filed 2021-08-05 | -$190.47M derived: sum of 3 quarters · filed 2021-08-05 | -$193.26M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2021-03-31 | -$67.92M 10-Q · filed 2021-05-06 | -$106.05M derived: sum of 2 quarters · filed 2021-05-06 | -$108.85M derived: sum of 3 quarters · filed 2021-11-04 | -$151.71M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-12-31 | -$38.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$40.93M derived: sum of 2 quarters · filed 2021-11-04 | -$83.78M derived: sum of 3 quarters · filed 2021-11-04 | -$130.33M 10-K · filed 2021-02-25 | ||||
| 2020-09-30 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$45.65M derived: sum of 2 quarters · filed 2021-11-04 | -$92.20M 10-Q · filed 2021-11-04 | -$108.45M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$42.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$89.40M 10-Q · filed 2021-08-05 | -$105.65M derived: sum of 3 quarters · filed 2021-08-05 | -$142.70M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$46.55M 10-Q · filed 2021-05-06 | -$62.80M derived: sum of 2 quarters · filed 2021-05-06 | -$99.84M derived: sum of 3 quarters · filed 2021-05-06 | -$114.04M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$16.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$53.30M derived: sum of 2 quarters · filed 2021-02-25 | -$67.50M derived: sum of 3 quarters · filed 2021-02-25 | -$93.80M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$37.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$51.24M derived: sum of 2 quarters · filed 2020-11-05 | -$77.55M 10-Q · filed 2020-11-05 | -$106.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$14.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$40.51M 10-Q · filed 2020-08-06 | -$69.54M derived: sum of 3 quarters · filed 2021-02-25 | -$89.63M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$26.31M 10-Q · filed 2020-05-11 | -$55.34M derived: sum of 2 quarters · filed 2021-02-25 | -$75.43M derived: sum of 3 quarters · filed 2021-02-25 | -$97.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$29.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$49.12M derived: sum of 2 quarters · filed 2021-02-25 | -$71.28M derived: sum of 3 quarters · filed 2021-02-25 | -$94.71M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$20.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$42.25M derived: sum of 2 quarters · filed 2019-11-06 | -$65.68M 10-Q · filed 2019-11-06 | -$86.48M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$22.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$45.58M 10-Q · filed 2019-08-05 | -$66.38M derived: sum of 3 quarters · filed 2020-02-27 | -$83.20M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$23.43M 10-Q · filed 2019-05-09 | -$44.23M derived: sum of 2 quarters · filed 2020-02-27 | -$61.05M derived: sum of 3 quarters · filed 2020-02-27 | -$78.21M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$37.62M derived: sum of 2 quarters · filed 2020-02-27 | -$54.78M derived: sum of 3 quarters · filed 2020-02-27 | -$76.54M 10-K · filed 2020-02-27 | -$76.73M 10-K · filed 2018-02-27 | |||
| 2017-09-30 | -$16.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$33.98M derived: sum of 2 quarters · filed 2018-10-30 | -$55.74M 10-Q · filed 2018-10-30 | -$55.93M 10-Q · filed 2017-11-07 | -$72.33M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-06-30 | -$17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$38.92M 10-Q · filed 2018-08-02 | -$39.11M 10-Q · filed 2017-08-03 | -$55.51M derived: sum of 3 quarters · filed 2019-02-27 | -$68.54M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | -$21.76M 10-Q · filed 2018-05-08 | -$21.95M 10-Q · filed 2017-05-08 | -$38.35M derived: sum of 2 quarters · filed 2019-02-27 | -$51.38M derived: sum of 3 quarters · filed 2019-02-27 | -$67.25M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | -$16.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$29.61M derived: sum of 2 quarters · filed 2019-02-27 | -$45.48M derived: sum of 3 quarters · filed 2019-02-27 | -$44.55M 10-K · filed 2019-02-27 | -$44.70M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$13.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$28.89M derived: sum of 2 quarters · filed 2017-11-07 | -$27.95M 10-Q · filed 2017-11-07 | -$40.42M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$15.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$14.93M 10-Q · filed 2017-08-03 | -$27.39M derived: sum of 3 quarters · filed 2018-02-27 | -$36.37M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $939.00K 10-Q · filed 2017-05-08 | -$11.52M derived: sum of 2 quarters · filed 2018-02-27 | -$20.50M derived: sum of 3 quarters · filed 2018-02-27 | -$29.45M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$12.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$21.44M derived: sum of 2 quarters · filed 2018-02-27 | -$30.39M derived: sum of 3 quarters · filed 2018-02-27 | -$44.21M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$8.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$17.93M derived: sum of 2 quarters · filed 2016-11-03 | -$31.75M 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | -$8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$22.77M 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | -$13.82M 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | -$53.22M 10-K · filed 2017-03-01 | |||||||
| 2013-12-31 | -$19.65M 10-K · filed 2016-02-25 |